Shareholders alert for Biopure Corp.

0 Comments | M2 Presswire, May, 2007

M2 PRESSWIRE-3 May 2007-Biotech News: Shareholders alert for Biopure Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:03052007 Shareholders alert for Biopure Corp (NASDAQ:BPUR) Biopure Corporation engages in the development, manufacture, and marketing of pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues.

It offers Oxyglobin for the treatment of anemia in dogs, primarily to veterinarians in the United States and Europe. The company provides Hemopure for the treatment of surgical patients, who are acutely anemic, as well as for eliminating, delaying, and reducing allogenic red blood cell transfusions in patients in South Africa. Biopure has applied for regulatory approval of a proposed...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)